Emily Hamman focuses her practice on patent prosecution, global patent portfolio management, and intellectual property strategy for technology and life sciences companies. She assists in advising clients ranging from early-stage startups to multibillion-dollar multinational corporations on developing and implementing U.S. and international patent strategies aligned with their business objectives.

Her experience centers on medical devices, such as wearables and implantable devices (e.g., biomarker sensing devices and neuromodulation technologies), drug delivery systems, and combination-device platforms. She also works on minimally invasive imaging systems, computer-assisted surgical navigation platforms, and robotic systems, and supports innovation in advanced biomedical technologies, such as platforms enabling cell engineering. In addition, Emily prepares and prosecutes patent applications directed to AI-driven solutions, microfluidics, optics, and consumer products. She assists in conducting freedom-to-operate, patentability, and IP diligence analyses in connection with financings, collaborations, and other strategic transactions.

Prior to joining Morrison Foerster, Emily worked in a development engineering capacity at a multibillion-dollar medical device company, where she supported product design and innovation efforts. She is currently a J.D. candidate at the George Washington University Law School.